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Activated macrophages  with  highly microbicidal properties  appear  in  the 
course of several important infections (1) and during a  graft-versus-host reac- 
tion.  1 They contribute largely (2) and sometimes exclusively (3) to the mech- 
anism of host resistance. The process of their activation involves immunological 
events which do not depend upon circulating antibody (4). Cells must therefore 
be considered for a  role not only in the ultimate expression of this type of im- 
munity but also in its mediation. Frenkel has shown convincingly that mice can 
be  adoptively protected  against  an  intracellular parasite,  Besnoitia jellisoni, 
with immune lymphoid cells (5). The present work complements these findings 
by  demonstrating  that  a  high level of specific immunity  and  a  proportional 
level of delayed-type hypersensitivity are conferred concurrently when  living 
lymphoid cells from the spleens of Listeria-infected mice are injected intrave- 
nously into normal recipients. 
Materials and Methods 
Animals.--The  mice  used throughout these studies were  specific pathogen-free females 
aged 5-6 wk. The colony, obtained from  Charles River Breeding Laboratories, North Wil- 
mington, Mass., has been maintained in an infection-free  environment.  Experimental ani- 
mals were kept under Isecaps  ® (Lab Cages Inc., Hackensazk, N. J.) on sterile litter and were 
fed on sterile, vitamin-enriched rations. 
Organisms.--Listeria monocytogenes (strain EGD) has been maintained by constant passage 
in mice for the past 12 months.  Suspensions for immunization or challenge  were prepared 
from  a  16 hr trypticase soy broth culture of infected spleen, The virulence  of the organism 
has increased during passage  from an initial intravenous ~50 of 1 X  105 to its current level 
ofSX 108. 
The strain of BCG (bacillus Calmette-Gu~rin)  used was Tice (Trudean Culture Collection). 
It was maintained on ATS  * egg medium but was used  as a  12 day primary subculture  in 
Tween-albumin  medium.  This was dispersed by ultrasound (20 kcs for 20 see) immediately 
prior to use. After enumeration in a Petroff-Hansser  chamber, it was diluted to an appropriate 
concentration in Hanks' BSS  (basic saline solution). 
• This investigation was supported by Grant No. AI 07015 from  the National Institute 
of Allergy and Infectious Diseases. 
z Blanden, R. V.  1969. Increased antibacterial resistance in the presence  of immunode- 
pression from a GHV reaction. Submitted for publication. 
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Immunization.--Mice were immunized against Lister~ monocytogenes by the intravenous 
injection of living organisms in a  dose which varied between 8  X  102 and 4  X  10  a.  Some 
mice failed to survive the immunizing infection at the higher dose levels. 
Preparation of Spleen Cell Suspensions.--Dissociated  spleen cells were prepared aseptically 
from normal or immunized mice. Batches of five spleens were diced and extruded through a 
60-mesh grid of stainless steel  After gentle pipetting,  the crude suspensions were  filtered 
through a  4  can column of acid-cleaned cotton wool  They were then washed  three times 
at 4°C in a large volume of Hanks' BSS containing 1% fetal calf serum (FCS). After a second 
passage through cotton wool, they were counted and brought to the desired concentration 
by appropriate dilution in 1% FCS in Hanks' BSS.  The final cell suspensions were highly 
heterogeneous but consisted predominantly of lymphoid cells of varying sizes.  They were 
almost devoid of recognizable macrophages which had been retained by the filter. Immedi- 
ately before injection, the viability of the cells was assessed by dye exclusion using 0.05% 
trypan blue in BSS. 
Test for Ddayed Hypersensitivity.--Delayed  hypersensitivity was measured in the footpad 
as previously described  (6).  The  test  antigens were  prepared from the filtrate of  a  96 hr 
trypticase soy broth culture of L. monocytogenes. The superuatant of a  centrifuged culture 
was brought to 75% saturation with ammonium sulfate. The floecnient deposit was dissolved 
in 0.01  M phosphate buffer at pH  7.4,  and separated into two protein-contalnlng fractions 
by exclusion chromatography on Sephadex G-50. The material used for sensitivity testing 
was contained in the first fraction. It was lyophilized and redissolved in phosphate-buffered 
saline. The antigen gave good footpad reactions in L/ster/a-infected mice with a dose containing 
2/~g protein. Routine tests were performed, however, with a dose of 20/~g protein in 0.02 ml. 
The injections were made with a 30 gauge needle introduced subcutaneously into the center 
of the plantar surface of the right hind foot.  Reactions were measured at 24 hr with dim 
gauge  calipers  (Scimelltaster, H.  C.  Kri~plin  GmbH, Schi~ichtern,  Hessen,  Germany). The 
difference in size between the right and left footpad (measured to 0.05 ram) was taken as the 
measure of hypersensitivity. The test  antigen produced  thickness increases which did not 
exceed 0.1 mm in unsensitized animals, 
Measurement of Prolecti¢e Immunity.--Protection against a challenge infection was meas- 
ured in  terms of the numbers of viable bacteria present in spleens and livers at intervals 
after  the  intravenous injection of  approximately 4  ~50's of L. monocytogenes. The  initial 
implantation of the challenge organism was obtained by plating homogenates of spleens and 
livers taken from five mice, 15 rain after injection. Its subsequent behavior was determined 
in groups of five mice killed 24, 48, and sometimes 72 hr after challenge. 
Microbicidal Activity of Peritoneal Macrophages.--Groups  of mice were injected intraperi- 
toneaily with 0.1 ml of  a  suspension containing approximately 10  s L. monoeytogenes in 10% 
immune mouse serum obtained from animals which had survived a  Listeria  infection. The 
antiserum was used to promote maximum phagocytosis of bacteria within 10 rain of residence 
in the peritoneal cavity, at which time, the peritoneal cavity of each mouse was washed out 
with 2.0 ml of cold BSS containing 10 IU heparin/ml. The washings were stood at 2°C until 
all samples had been recovered. Three aiiquots of 0.3 ml were then diluted in 12 X  75 mm 
tubes containing 0.5 ml of 1% FCS. One was retained at 2°C, the others were incubated at 
37°C  for 30 rain or 60 rain. At these times one tube from each group was chilled to 2°C to 
halt further bacterial inactivation.  3 All tubes were then centrifuged for 8 rain at 200 g. After 
plating 0.1 ml samples of the supernatant, which contained few, if any, extracellular organisms, 
the tubes were drained, and the deposited cells resuspended in  1.0 ml of 1% FCS in BSS. 
The cells were then disrupted by ultrasound (Biosonik) at 20 kcs for 10 sec. Volumes of 0.i ml 
of disrupted  cells were plated in duplicate to determine the initial number of intracellular 
bacteria and the percentage survival after 30 and 60 rain. 
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RESULTS 
The Development o.[ ImmunologicalIy  Active Lymphoid Cells in the Spleens  of 
Listeria-infected  Mice.--It was learned from preliminary studies that an intra- 
venous injection of 10  s immune spleen cells, taken on the 7th day of a primary 
Listeria infection, would protect normal recipients against a  lethal challenge 
with L. monocytogenes. Their rate of development and the persistence of the 
population of cells which could immunize recipient mice was studied in an ex- 
periment which could be performed only by dividing it into two parts.  The 
animals used as immune spleen cell donors on the 4th, 5th, and 6th days of a 
primary Listeria infection were immunized intravenously with 1.1 X  l(P viable 
L. monocytogenes. Those used for cell transfer on days 7, 8, 12, and 20 received a 
slightly smaller immunizing dose of 0.8 ×  103 viable Listeria.  At each transfer, 
recipients received 2 X  10  s filtered spleen ceils, the viability of which varied be- 
tween 79 and 84 %. The challenge organism was mixed with the cell suspension 
and injected intravenously into recipients in a  volume of 0.5 ml. The actual 
viable counts per inoculum varied from day to day, but fell between 0.8 and 
3.0 ×  104. At each day of transfer, an equal number of normal control mice was 
injected with the same number of L/ster/a but no cells. As there was a small but 
unavoidable variation from day to day in the numbers of organisms used for 
challenge, the experimental results have been expressed in Fig. 1 as the differ- 
ence in the log viable counts found at 24 and 48 hr. The base line for this calcu- 
lation was taken as the mean viable counts found in spleens and livers of both 
the control and cell-injected mice sacrificed 15 rain after challenge. Each point 
of the growth curve of Listeria in normal mice is the mean of 35 viable counts 
obtained in mice which received no cells. 
The results in Fig. 1 show little protective effect from ceils harvested on the 
4th day of an immunizing Listeria infection. The high 24 hr liver counts at this 
time were probably due to a carry over of bacteria in the spleen cell suspensions 
prepared from actively infected donors whose spleens would still contain large 
numbers of organisms at this stage of infection (3). A rapid and progressive in- 
crease occurred in the efficiency of the immunity transferred with a  standard 
dose of immune lymphoid ceils harvested between the 4th and 6th or 7th days 
of the immunizing infection. Beyond that time, the protective effect diminished 
but was still substantial in animals receiving cells from 20-day immune donors. 
For practical reasons, the control mice in this experiment were not injected with 
spleen ceils  from unimmunized donors.  Subsequent experiments will demon- 
strate  that  equivalent numbers  of normal spleen  cells  do not influence the 
growth of Listeria in spleen or liver. 
The relative efficiencies of cells obtained at different stages of an immunizing 
infection are more dearly depicted in Fig. 2, in which the data from the 48 hr 
counts in spleen and liver have been plotted against the time of cell harvest. 
Dose-Response Relationship.--Since  cells obtained on day 7 of the primary 976  LYMPHOID  CELLS  AND  MACROPHAGE  ACTIVITY 
infection appeared to be optimally protective, donors were used at this time to 
determine the minimum number of cells needed to produce a detectable level of 
immunity in normal recipients. Spleen cells from a  pool of immunized donors 
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FIG.  1.  Growth curves  showing the inhibition of a  Listeria challenge  in the livers and 
spleens  of mice protected with 10  s lymphoid cells from  the spleens  of immunized  donors. 
The curves  are numbered  for the day of the immunizing  infection upon which cell transfer 
was made. The normal controls (N)  did not received spleen ceils. Means of 5. 
were injected in varying numbers into recipients which had been challenged ] 5 
rain previously with  an  inoculum  of  1.1  X  104  viable L.  monocytogenes. The 
initial implantation of organisms in spleen and liver was determined in counts 
on five mice killed immediately prior to cell transfer. The cell suspension used G.  B.  ~ACKAm~SS  977 
for transfer was 86 %  viable. Control mice received 2  X  108 spleen cells from 
unimmunized donors. 
Fig. 3 shows the varying degree of protection conferred with graded doses of 
immune spleen cells.  Mice injected with a large number of immune cells (2  X 
108  ) showed progressive elimination of the challenge organism from the spleen 
(B) in contrast to its rapid growth in recipients of an equivalent number of nor- 
mal spleen cells.  Fewer immune cells produced proportionally less protection in 
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FIG. 2. Curves describing the development of a population of immunologically  committed 
cells in the spleens of Lister/a-infected mice. The curves were developed from the 48 hr counts 
recorded in Fig. 1, and show for spleen (O) and liver (O) the differences (Logl0) between 
the viable counts found in normal mice and mice injected with 10  s cells obtained from spleens 
at varying stages of the immunizing Listeria infection. 
both spleen and liver. It is not clear why the 24 hr counts in the livers of animals 
which received smaller numbers of immune cells should have been so high.  It 
may have resulted from the presence of viable bacteria in the spleen cell inoc- 
ulum, which lacked the countering influence of a su/ficient number of immune 
cells to control them. Since 90 % of bacteria inoculated intravenously are taken 
up by the liver, bacterial contamination of the spleen cell suspension would  be 
more sharply reflected in liver than in  spleen. 
Comparison of Passive Immunization  with Cells and Serum.--Donor mice were 
immunized by the intravenous injection of 6.4 X  10  * living L. monocytogenes. 8 978  LYMIPHOID CELLS AND MACROPIZAGE ACTIVITY 
days later  the immune mice, and a larger  group of normal donors, were bled 
from the retro-orbital  plexus.  Their spleens  were then used to prepare filtered 
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FIG. 3. Growth curves showing the protective effect of varying numbers of immune lymph- 
oid cells from the spleens of 7-day immune donors. Recipients injected with normal cells 
in a dose of 2 X  10  8 (A) or immune cells in doses of 2 X  l0  s (B), 4 X  l0  T(C),8 X  10  6 
(D) and 2 X  10  e (E). Means of 5. 
cell suspensions. While the cells were being washed, the serum was  separated 
and pooled. Two groups of mice were injected intravenously  with 0.5 ml of sus- 
pensions containing 3.7  X  104 viable L~steria and 2  X  10  s normal or  immune G.  ]3.  ~ACZAm~SS  979 
lymphoid cells of 75 and 72 % viability, respectively. Two other groups of mice 
were injected intravenously with the same numbers of organisms suspended in 
0.5 ml of serum from the same normal or immune donors. These had been in- 
cubated for 60 min at 37°C prior to injection. A third category of two groups of 
mice were injected with L. monocytogenes which had been incubated at 37°C for 
1 hr in the presence of the normal or immune lymphoid cells at a concentration 
of 2 X  109 cells and 2 X  10  ~  bacteria per ml; after 1:10 dilution, these mixtures 
were disrupted by ultrasound for 20 sec at 20 kcs. This sufficed to disrupt more 
than 90 % of the ceils without affecting the viability of the bacteria present in 
the mixture. 
The growth curves of L. monocytogenes in the recipients of normal or immune 
spleen cells are depicted in Fig. 4A. In comparison with the recipients of normal 
cells, the spleens of mice receiving lymphoid ceils from immune donors showed 
an immediate protection resulting in the death of 95 % of the inoculum over a 
period of 48 hr. The effect in the liver was less pronounced at 24 hr, but by 48 
hr, the livers showed a degree of protection similar to that found in the spleen. 
In almost every experiment reported here, and in an accompanying paper (7), 
the protection conferred by immune cells was seen immediately in the spleen hut 
was delayed in the liver. 
In contrast to the striking protection afforded by immune lymphoid cells, the 
transfer of 0.5 ml of immune serum had no discernible effect upon'the growth 
pattern of L. monocytogenes in the spleens or livers of recipient mice even though 
the bacteria had been incubated in the serum for 60 min prior to injection (Fig. 
4B).  Moreover, incubation of the bacterial inoculum with immune lymphoid 
cells had no influence on the subsequent behavior of the organism, provided that 
cells were killed prior to transfer (Fig. 4C). This is taken as evidence that the 
secretion of an antibacterial  antibody is not responsible for host resistance. 
Nonetheless, immune lymphoid cells can confer protection, but can do so only 
if they are viable. 
Concurrent Transfer of Immunity and Specific Hypersensitivity with Immune 
Lympkoid  Cells.--Donor  mice were immunized intravenously with 1.1  X  108 
viable L. monocytogenes. At daily intervals, 10 mice were used to measure the 
level of delayed hypersensitivity in the donors. On days 5, 6, and 7 of the in- 
fection, when the greatest variation had been found in the protective efficiency 
of spleen cells, 25 of the immunized mice were used as donors for the transfer of 
108 spleen cells to 25 normal recipients. 10 of these were used immediately to 
test the level of hypersensitivity in recipients, the reactions being read after 24 
hr. The other 15 recipients, together with 15 normal mice, were challenged with 
approximately 1 X  104 viable Listeria. Mter 15 rain, and again at 24 and 48 hr, 
bacterial counts were made on spleens and livers from five normal and five 
passively immunized mice. The results are recorded in Fig. 5 as the difference in 
log viable counts in the spleens of normal and immune cell recipients. They 
show that maximum protection was achieved with cells harvested on day 6. 5 
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Fig. 5 also shows that the 6th day corresponded to the time of maximum foot- 
pad reactivity to Listeria antigen  not only in  the  cell  donors but  also  in  cell 
recipients. 
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FIG. 4. A. Comparative growth curves of a Listera challenge in the livers (0) and spleens 
(O) of mice injected with 2 X  l0  s spleen cells from normal  (  ) or 7-day immune donors 
(-  .... ). B.  Growth curves of L. monocytogenes in animals which received only serum from 
the normal  and immune donors described in A. The organisms were incubated  with  the 
sera before injection.  Groups as designated in A. Means  of 5. C.  Growth curves obtained 
with inocula of L/ster/a which had been incubated in the presence of the normal or immune 
spleen cells used in A. The cells were disrupted by ultrasound immediately prior to injection. 
Means of S. 
The Effect of Mitomycin C on Adoptive Immunization with Cells.--It has been 
reported that the capacity of cells to transfer delayed-type hypersensitivity is 
impaired  or ablated  by pretreatment  with mitomycin C  (8).  Its influence  on 
cell-mediated  protection  against  lethal  challenge  with  L.  monocytogenes  was 
examined in the following experiments. 
Filtered spleen cells from 7-day immune donors were suspended in 1% FCS. 
48 G. B.  ~CX~mSS  981 
Mitomycin C was added to half of the cells at a concentration of 1.0 ug/ml. The 
treated and untreated cells were then incubated for 60 mln at 37°C, washed in 
BSS and resuspended in 1% FCS in BSS. Mter counting, they were diluted to 
contain 2.0 X  108 cells/ml. A group of control mice were injected with an equal 
number of cells from normal donors. These were also treated with mitomycin C. 
Recipients were challenged with L. monocytogenes 15 rain prior to cell transfer. 
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FIo. 5. Comparison between protection (hatched) and level of hypersensitivity (white) 
conferred with 10  s spleen cells from 5, 6 or 7 day-immune  mice. The level of hypersenfitivity 
in the donors is shown in black.Protection is expressed as the difference(A)  between log viable 
count in the spleens of normal and immune ceil recipients. Recipients of normal ceils gave 
no measurable reaction to Lis~ria antigens. Means of 5. 
The effect of treating Listeria-immune spleen cells with mitomycin C is shown 
in Fig. 6. The cells were of low viability at the time of transfer (50 and 55 % 
viable for treated and untreated cells,  respectively). Those treated with mito- 
mycin C,  though no less viable, showed some reduction in their capacity to 
inhibit the growth of the challenge organism. 
The foregoing experiment was repeated at a higher drug concentration. When 
exposed to mitomycin C  at a concentration of 10 #g/ml, which is still low in 
comparison with that used by Bloom, Hamilton, and Chase (8), the cells re- 
tained their viability (82 %)  and some of their protective capacity remained 
intact (Fig. 7). It is of considerable interest that resistance increased progres- 982  LYMPHOID  CELLS  AND  MACROPHAGE  ACTIVITY 
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FIo.  7.  Growth curves of L.  monocytogenes in mice injected with  10  s  spleen cells from 
normal or L/ster/a-immune mice. HaLf of the immune cells  (A)  and the normal ceils  (0) 
were incubated in the presence of mitomycin C  (10 #g/mi) for 1 hr prior to transfer. The 
third group {1) received untreated immune ceils. 
e/e 
FIo.  6.  Growth curves of L.  monocytogenes in mice injected with  l0  s  spleen cells from 
normal mice  (0)  or L/ster/a-immune mice. The latter were incubated in the presence  (A) 
or absence (ll)  of mitomycin C  (1.0/~g/ml) prior to transfer. Means of 5. 
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sively in the animals which received untreated cells, but not in the recipients of 
cells which had been treated with mitomycin C. No detectable organisms could 
be found at 72 hr in spleens or livers of the former, whereas the latter showed a 
small but progressive increase in bacterial count over the whole period. 
.o 
_o 5 
O 
o 
/ 
\ 
\ 
\ 
\ 
\  \ 
\  \ 
\  : 
\ 
\ 
\ 
\ 
o 
211  I  I  ! 
1  24  48  72 
Hr 
FIo. 8. Growth curves of L. monocylogenes in the spleens (O) and livers (0) of mice in- 
jeered with l0  s spleen cells from normal (~)  or L/ster/a4mmune donors (  ~: ) which 
received their immunizing infection 12 days before cell transfer. Means of 5. 
The foregoing experiment suggested that mitomycin C,  at the higher con- 
centration, had prevented proliferation of donor cells in the recipient, leaving 
other metabolic activities intact. The degree of protection conferred by immune 
lymphoid cells may depend therefore upon donor cell proliferation in the recip- 
ient. This possibility receives support from an  experiment (Fig.  8)  in which 
immune cells were obtained on day 12 when the active phase of the immune 
response in  the donors had subsided.  Upon transfer to normal recipients,  a 984  LYMPHOID  CELLS AND  M-ACROPHAGE  ACTIVITY 
standard dose of these immune cells  (108) gave only a low level of resistence 
during the first 48 hr.  Between 48  and  72  hr,  however, resistance mounted 
steeply as indicated by a dramatic fall of viable counts in spleens and livers. This 
could mean that some of the committed cells did not become functional until 
some time after transfer, or more plausibly that the committed cells became 
augmented in number by active proliferation in the tissues of the recipient. The 
latter explanation receives  support from other observations  4 which show that 
vinblastine (a mitotic poison) effectively suppresses the immunity conferred by 
a population of Listeria-immune  lymphoid cells when given to recipients at the 
time of cell transfer. 
The Specificity  of Adoptive Antibacterial Immunity.--Animals  infected with 
BCG become highly resistant to challenge with L. monocytogenes (9). It was of 
interest to see whether this nonspecific resistance could be passively transferred 
with spleen cells. Evidence from a previous study (4) suggested that lymphoid 
cells from BCG-immunized mice would probably not protect normal recipients 
against a Listeria challenge, but that some degree of resistance might develop 
if the recipients were stimulated with an appropriate dose of living BCG. The 
following experiment was designed with this possibility in mind. 
Mice were immunized by the intravenous injection of 1.2 X  108 living BCG. 
21 days later, these animals were highly sensitive to tuberculin. Some of them, 
together with a group of normal mice, were used to prepare filtered spleen cell 
suspensions. The remainder, and an equal number of normal mice, were used to 
compare the growth of L. monocytogenes in the spleens of the normal and im- 
mune cell donors. Two groups of recipients were injected intravenously with 
cells from the normal or BCG-immunized donors. Together with the cells, half 
of each received an inoculum of living BCG (1.1 X  106). All animals were then 
challenged with L. monocytogenes. Spleen and liver counts were performed on 
five mice from each of the six groups, 24 and 48 hr after challenge. 
The results recorded in Fig. 9 show that BCG-immunized donors (E)  were 
highly resistant to challenge with L. monocytogenes; but recipients of lymphoid 
cells from these animals were no more resistant than normal mice (F)  or the 
recipients of normal cells  (C). Those receiving both immune spleen cells  and 
living BCG (B) became partially resistant. This effect of a small inoculum of 
BCG was not seen in the recipients of normal cells (D). The result is interpreted 
to mean that resistance conferred with immune lymphoid cells is specific for the 
infective agent, and that the antibacterial mechanism which develops in the 
recipients of immune spleen cells is dependent upon some form of interaction 
between  the  specifically sensitized  cells  and  the  organism  or  its  antigenic 
products. 
Activation of Peritoneal Macrophages in Adoptively Immunized Mice.--It was 
* Tripathy, S. P., and G. B. Mackaness. 1969. The effect of cytotoxic agents on the passive 
transfer of cell-mediated immunity. Submitted for publication. G. B. ~C~SS  985 
found in a recent study (9) that the injection d  BCG into tuberculin sensitive 
mice causes a  marked and rapid increase in resistance to challenge with L. 
~nonocytogcnes. It was accompanied by changes in the morphology and micro- 
bicidal activity of free macrophages in the peritoneal  cavity. A similar effect 
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FIG.  9.  The curves illustrate  the behaviour of a  population of L.  rnonocytogen~s in  the 
spleens of mice which had received 10  8 normal  (C and  D) or BCG-immunized spleen cells 
(A and B); and in the spleens of the normal (F) or immune (E) donors. Half of the recipients 
of normal  (D)  and ;mmune  (B) cells were also injected with a  small dose of BCG at the 
same time. The curves show that the immune donors were List~da resistant  (E). However, 
the recipients of cells from these donors were no more resistant than normal animals (F) or 
the recipients of normal cells (C). The injection of BCG produced a statistically significant 
increase in resistance only in the recipients of BCG-sensitized lymphoid cells (B). This dose 
of BCG had no effect on the resistance of recipients given normal cells (]3). 
was therefore sought in mice which had been passively sensitized with lymphoid 
cells from tuberculin sensitive donors. 
Spleen  cell donors were immunized intravenously with approximately 10  s 
viable units of BCG. 14 days later, spleen cells from these and a larger group of 
normal mice were prepared for transfer to normal recipients in a dose of 2 X  108 
cells,  l0 recipients of normal or immune spleen cells were tested for tuberculin 986  LYMPHOID  CELLS  AND  MACROPHAGE  ACTIVITY 
hypersensitivity. Half of the remaining mice in each group were injected with 
living BCG (1  X  107). After 24 and 48 hr, five mice from each of the 4 groups 
were used to examine microbicidal activity in the macrophages of the peritoneal 
cavity as described in the methods. 
No significant differences were found between groups in respect to the micro- 
bicidal activities of macrophages tested 24 hr after cell transfer. But at 48 hr, a 
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1~o. 10. Curves showing percentage survival of L. momwytog~tes in peritoneal macrophages 
obtained 48 hr after injection of: I. 2  ×  l0  s normal spleen cells.  II. 2  X  10  s normal spleen 
cells "4- 107 BCG. III. 2  X  10  s BCG-immaniz~ spleen cells.  IV. 2  X  l0  s BCG-immunized 
spleen cells q-  107 BCG. Brackets enclose the full range of values obtained in group IV and 
groups I, II, and HI. Means of 5 mice. 
difference had developed (Fig. 10). The macrophages of recipients of immune 
lymphoid cells alone were normal, but mlcrobicidal activity was considerably 
enhanced in animals which had received an eliciting dose of BCG in addition to 
sensitized cells.  Moreover,  the macrophages from this group of mice spread 
rapidly on glass when a sample of the peritoneal washings was placed in culture, 
a feature characteristic of activated macrophages (9, 10).  1, 5 
5 North, R.  ].  1969.  Cellular responses leading to  acquired  cellular resistance. Prepared 
for  publication. c.  ~.  m~C~ESS  987 
DISCUSSION 
Acquired resistance to Listeria monocytogenes rests finally with the activated 
macrophages which are so conspicuous a feature of the response to this and other 
facultative intracellular  parasites  (1),  but immune macrophages  can  protect 
normal recipients only when given the opportunity to interact directly with the 
organisms of the challenge infection (11). Their defensive role seems therefore to 
be limited to their capacity to kill ingested organisms  with enhanced efficiency. 
In other words, they lack the immunological  properties which would permit the 
host to develop its own defense against infection. It is significant,  therefore, that 
the  immune  macrophage  also  lacks  the  capacity  to  transfer  delayed-type 
hypersensitivity  (12).  This  function  is  subserved by cells  belonging  to  the 
lymphoid series, as is indicated by their representation in regional lymph nodes 
(13), among the nonphagocytic components of cellular exudates (5), and in the 
cells of thoracic duct lymph (13, 14). 
Filtered spleen cell suspensions  obtained  from  Listeria-infected  mice  were 
found to contain the cellular elements necessary for the adoptive transfer of both 
hypersensitivity and  protection  against L.  monocytogenes. Both of these im- 
portant immunological  modalities appeared in recipients at levels which bore a 
quantitative  relationship,  one to the other.  Futhermore,  antimicrobial  resis- 
tance and delayed-type hypersensitivity arise concurrently in Listeria-infected 
mice (3). It is, therefore, tempting to infer that both are mediated by a single 
population of committed cells. 
Little is known about the cells which perform these two important immunol- 
ogical functions. Something has been learned from the present study of the rate 
at which they appear in the spleen (Figs. 1 and 2), while a companion paper (7) 
reveals that they are extremely sensitive to inactivation by an anti-lymphocyte 
globulin (ALG) which does not react with macrophages.  It seems,  therefore, 
that the cells which can adoptively protect recipients against a Listeria infection 
are lymphoid in nature, even though ALG may not be uniquely specific for cells 
of this type (15). 
When spleen cells were harvested from donors at progressive stages of an 
immunizing  infection, the efficiency of the protection they conferred rose steeply 
from the 4th to the 6th or 7th day (Fig.  2). In studying the mitotic activity in 
the spleens of Listeria-infected  mice, North  5 found that the percentage of cells 
engaged in DNA synthesis rose sharply to a briefly sustained peak at 48 hr. 
Most of the dividing cells were blast forms. Since transfer of resistance was not 
achieved with spleen cells harvested 2 days after the time of the peak mitotic 
response (Fig. 1), it seems that committed lymphoid cells are still few in number 
at this time. If the early mitotic activity is due in part, though probably not 
entirely  ~, to cells engaged in the immune response to Listeria, the slow increase 
in the numbers of cells which can sensitize  or protect normal recipients is diffi- 
cult to understand. It may mean that the progeny of the dividing cells leave the 988  LYMPHOID  CELLS  AND  MACROPHAGE  ACTIVITY 
spleen soon after they are formed, or that a protracted period of maturation is 
necessary before they acquire full competence to perform the functions of a 
committed cell. The latter is unlikely in view of other evidence  5, s which places 
the onset of immunity as early as 24 hr after infection. This leaves the first 
alternative, which is supported by the findings of Hall et al. (16) who showed 
that antibody-forming cells  are released from regionally stimulated nodes. If 
the same is true of the cells engaged in the immune response to living Listeria, 
the spleen might not acquire its greatest content of committed cells until the 
6th or 7th day because it takes time for the newly formed cells to reach equilib- 
rium with the entire pool of recirculating cells. This explanation assumes that 
the cells  concerned in the mediation of acquired resistance are able to recir- 
culate. Several points suggest that they can. First, they are present in thoracic 
duct lymph, which is a point on the pathway of recirculating cells  (17).  Sec- 
ond, cell donors show maximum reactivity to Listeria antigens on day 6 of a 
primary infection initiated with a small inoculum? This corresponds to the time 
when committed cells are most highly represented in the spleen (Figs. 1 and 2), 
a  fact which suggests that reactive cells  have become uniformly distributed 
through blood and lymphoid tissues by the 6th day of infection. Finally, there is 
the significant finding that  resistance usually appeared more rapidly in  the 
spleens than in the livers of adoptively immunized animals. 
The  last  point  requires  elaboration.  The  tendency  of lymphoid  cells  to 
"home" on the spleen  and other lymphoid organs (18)  offers a  possible ex- 
planation for the observed difference in the rate at which resistance appears in 
the spleens and livers of passively immunized mice. If transferred cells accu- 
muiate more abundantly in the spleen, this organ might be protected sooner 
than the liver.  To investigate this  possibility, Listeria-infected  donors were 
injected repeatedly with tritiated thymidine during the period of peak mitotic 
activity in the spleen/Six days later, their spleen cells were used for passive 
transfer to normal recipients. Approximately 24 % of the transferred cells were 
labeled. The distribution of radioactivity in the organs of the recipients showed 
that the spleens acquired approximately 10  times as much radioactivity per 
unit weight as did the liver. This suggests that the labeled cells in the population 
were selectively removed by lymphoid organs. If a majority of the labeled cells 
in the transferred population were specifically committed to Listeria antigens, it 
would follow that committed cells can reenter the lymphoid tissue. This would 
make it possible for them to reach a maximum representation in the spleen at a 
time when their production has long since ceased. It might also explain why the 
spleen is immediately protected by transferred cells. 
Several points can be made in regard to the manner in which immune lymph- 
6 Tripathy,  S.  P.,  and  G.  B.  Mackaness.  1969.  The  effect  of  cytotoxic  agents  on  the 
primary immune response to Listeria monocytogenes. Submitted for publication. 
7 Sutton, J. S., and G. B. Mackaness. Data to be published. G. B.  ~ACKANESS  989 
oid cells accomplish the task of protecting normal recipients against a Listeria 
challenge. Three lines of evidence indicate that they do so by indirect means. 
(a)  Bacteria which had been incubated with immune lymphoid cells  were 
uninfluenced in their behavior when injected into mice (Fig. 4C). If immune 
cells produce an antibacterial  antibody, it should have been revealed in this ex- 
periment, for the cells themselves conferred immediate protection upon normal 
recipients (Fig. 4A). The earliest observations in the present studies were made 
12 hr after transfer, at which time spleens of passively immunized animals had 
already inactivated most of the organisms implanted there. 
(b) Immune lymphoid ceils are devoid of protective activity when transferred 
to X-irradiated recipients.  * Their defensive function must depend,  therefore, 
upon the intervention of a radiosensitive cell supplied by the recipient. Volkman 
and Collins (19) s have shown that monocyte precursors are highly radiosensi- 
tire.  If their production by the bone marrow is interrupted in animals with 
delayed-type hypersensitivity, reactivity to antigen disappears until monocyte 
production is resumed. In view of these findings, the circulating monocytes 
would seem to be intimately concerned not only in the classical manifestations 
of a  delayed-type hypersensitivity reaction in the skin, but also with the ex- 
pression of cell-mediated forms of acquired antimicrobial resistance. It would 
seem, in fact, that the immune lymphoid cells do not themselves accomplish the 
death of the parasite, but can influence host cells to achieve this end. 
(c)  Finally, the lymphoid cells  of BCG-immunized donors were unable to 
protect normal recipients against a Listeria challenge even though the donors 
themselves were highly resistant to this organism (Fig. 9). Herein lies the ele- 
ment of specificity in acquired cellular resistance. Only when the recipients of 
cells from BCG-sensitized donors were injected with BCG did some degree of 
non-specific resistance develop against Listeria. The resistance mechanism must 
be assumed, therefore, to depend upon the interaction between the lymphoid 
cells  and the microbial antigens with which they are  reactive,  It would be 
speculative to conclude that this interaction results somehow in the production 
of activated macrophages in the recipient were it not for the finding that per- 
itoneal macrophages became altered in morphology and microbicidal activity 
(Fig. 10) under similar experimental conditions. When spleen cells from BCG- 
sensitized animals were transferred to normal recipients, no effects were seen in 
the free macrophages of the peritoneal cavity unless BCG was injected at the 
same time. Apparently, activated macrophages arise in the wake of a delayed- 
type hypersensitivity reaction which need not necessarily take place in their 
immediate vicinity~ Although the effect of injecting BCG into passively im- 
munized mice was not impressive, it was nonetheless significant, particularly as 
s Collins, F.  M., and A. Volkman. 1969. Suppression of delayed hypersensitivity and 
its subsequent recovery  following  X-radiation. Submitted for publication. 990  LYMPHOID CELLS AND  MACROPHAGE  ACTMTY 
an eliciting dose of BCG takes 3 days to produce its maximum effect even in 
actively immunized mice (9)~ 
The activation of host macrophages would seem from these findings to depend 
upon a humoral factor which is released by reactive lymphoid cells in the pres- 
ence of specific antigen. A substance which circulates seems necessary to explain 
the effects observed in the peritoneal cavity of an animal which received sensi- 
tive cells and bacteria by intravenous injection. The migration inhibitory factor 
(MIF) (20, 21) could fulfill the role of the hypothetical humoral mediator which 
influences macrophage function. If MIF were to stimulate macrophages metab- 
olically, it might induce in them the functional and morphological properties 
found in the acitvated macrophages of infected animals. 
The release by lymphoid cells of a factor which causes systemic changes in 
macrophage activity would explain why resistance is usually slower to develop 
in the livers than in the spleens of adoptively immunized animals, If most of it 
were produced in lymphoid tissues, because reactive cells are more abundant 
there, its effects would appear more slowly in the liver and still more slowly in 
the peritoneal cavity, 
Consideration must be given to an alternative explanation for the protective 
properties of immune lymphoid cells. They could secrete a cytophilic antibody 
which is so avidly bound by cells that it is effectively  absent from serum. It can 
be imagined that specific antibody on the surface of macrophages would render 
them sensitive to antigen. It is already known that anti-mouse cell antibodies in 
newborn calf serum stimulate pinocytosis and raise the synthetic activity of 
macrophages in vitro (22). It is conceivable that antibody on the cell surface and 
microbial antigen in the cell's environment would have a similar effect. There is 
as yet no evidence that acquired cellular resistance depends upon cytophilic 
antibody. If it does, the activation of macrophages would require  that free 
antigen be available and disseminated widely enough to influence cells in se- 
cluded areas such  as the peritoneal cavity. That such things can happen is 
unequivocally attested by the macrophage disappearance  reaction of Nelson 
and Boyden (23). 
When immune lymphoid cells were transferred in small numbers (Fig. 3), or 
were harvested late in the immunizing infection (Fig. 8), low levels of resistance 
were found in recipients during the first 24 or 48 hr after transfer. A little later, 
the level of resistance rose sharply as indicated by a  sudden drop in viable 
bacteria. This delayed onset of resistance did not occur with cells which had 
been treated with mitomycin C (Fig. 7). As mitomycin C can interfere with cell 
division without abolishing protein synthesis (24),  these findings imply that 
immunologically committed cells  can augment their contribution to host de- 
fenses by proliferation, so that the cells involved may be antigen-sensitive in a 
manner analogous to that of the memory cells which become engaged in a sec- 
ondary antibody response.  A  similar conclusion was  reached by Bauer  and G. B.  MACKANESS  991 
Stone (25) in regard to the passive transfer of tuberculin sensitivity in guinea 
pigs. 
SUMMARY 
It has been shown that the immune response of mice to infection with L. 
monocytoge~s gives rise to a population of immunologically committed lymph- 
oid cells which have the capacity to confer protection and a proportionate level 
of delayed-type hypersensitivity upon normal recipients. The cells were most 
numerous in the spleen on the 6th or 7th day of infection, but persisted for at 
least 20 days. Further study revealed that the immune cells must be alive in 
order to confer protection, and free to multiply in the tissues of the recipient if 
they are to provide maximum resistance to a  challenge infection. The anti- 
bacterial resistance conferred with immune lymphoid cells is not due to anti- 
bacterial antibody; it is mediated indirectly through the macrophages of the 
recipient. These become activated by a process which appears to depend upon 
some form of specific interaction between the immune lymphoid cells and the 
infecting organism. This was deduced from the finding that immune lymphoid 
cells from BCG-immunized donors, which were highly but nonspecifically re- 
sistant to L/ster/a, failed to protect normal recipients against a Listeria challenge 
unless the recipients were also injected with an eliciting dose of BCG. The peri- 
toneal macrophages of anlmais so treated developed the morphology and micro- 
bicidal features of activated macrophages. It is inferred that acquired resistance 
depends upon the activation of host macrophages through a product resulting 
from specific interaction between sensitized lymphoid cells and the organism or 
or its antigenic products. Discussion is also made of the possibility that activa- 
tion of macrophages could be dependent upon antigenic stimulation of macro- 
phages sensitized by a cytophilic antibody. 
The technical assistance of Mr. Donald Auclair is grat~ully acknowledged. 
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